In a report released yesterday, from CICC maintained a Buy rating on OrbusNeich Medical Group Holdings Limited, with a price target of HK$5.30....
Currently, the analyst consensus on OrbusNeich Medical Group Holdings Limited is a Moderate Buy with an average price target of HK$5.30.
Based on OrbusNeich Medical Group Holdings Limited’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of HK$96.9 million and a net profit of HK$22.11 million. In comparison, last year the company earned a revenue of HK$85.19 million and had a net profit of HK$20.89 million
In a report released yesterday, from Citi maintained a Buy rating on C&D International Investment Group Ltd., with a price…
CICC analyst maintained a Buy rating on Bosideng International Holdings yesterday and set a price target of HK$5.65. The…
In a report released yesterday, from CICC maintained a Buy rating on JD Health International, Inc., with a price target of…
CICC analyst maintained a Buy rating on ZJLD Group, Inc. on June 5 and set a price target of HK$11.20. The company’s shares…
In a report released yesterday, from CICC maintained a Buy rating on BOC Hong Kong (Holdings), with a price target of…
In a report released on July 18, from CICC maintained a Buy rating on C&D International Investment Group Ltd., with a price…
